Skip to main content

Want a detailed portfolio tracker?

Third Harmonic Bio (THRD) P/E (2022 - 2026)

Third Harmonic Bio (THRD) P/E from Sep 14, 2022 to Jun 2, 2026. The TTM Third Harmonic Bio (THRD) P/E is -4.42. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Third Harmonic Bio (THRD)

YearP/EChange
2026-4.42N/A
2025-4.42-54.46%
2024-9.72-20.51%
2023-12.22+1772.36%
2022-0.65N/A

Comparison Third Harmonic Bio (THRD) P/E with competitors

Third Harmonic Bio (THRD) P/E is -4.42.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.10-102.31%
ENLVEnlivex Therapeutics Ltd0.15-103.39%
FGENFibroGen Inc0.24-105.43%
TRAWTraws Pharma Inc0.47-110.69%
FBIOFortress Biotech Inc0.71-115.96%
CHRSCoherus Biosciences Inc0.98-122.11%
ORMPOramed Pharmaceuticals Inc1.47-133.30%
AGENAgenus Inc2.05-146.30%
VIVSVivoSim Labs Inc2.54-157.31%
INVAInnoviva Inc3.19-172.06%
CRMDCorMedix Inc3.65-182.40%
ABEOAbeona Therapeutics Inc4.20-195.04%
VXRTVaxart Inc4.26-196.32%
CVACCureVac N.V.4.45-200.48%
SRPTSarepta Therapeutics Inc4.62-204.51%
GLPGGalapagos NV4.86-209.82%
RIGLRigel Pharmaceuticals4.92-211.19%
ZVRAZevra Therapeutics Inc4.97-212.42%
ABUSArbutus Biopharma Corp5.69-228.69%
CGENCompugen Ltd7.38-266.89%
AUPHAurinia Pharmaceuticals Inc9.25-309.10%
ACADAcadia Pharmaceuticals Inc9.59-316.70%
OMEROmeros Corporation9.88-323.38%
PLXProtalix BioTherapeutics Inc9.91-323.96%
SPROSpero Therapeutics Inc10.73-342.62%
ADMAAdma Biologics Inc11.33-356.09%
SVASinovac Biotech Ltd11.44-358.47%
TBPHTheravance Biopharma Inc11.78-366.17%
HRMYHarmony Biosciences Holdings Inc12.18-375.30%
TGTXTG Therapeutics Inc13.18-397.88%
INCYIncyte Corp13.38-402.45%
SABSSAB Biotherapeutics Inc14.06-417.73%
XOMAXOMA Corp14.95-437.79%
REGNRegeneron Pharmaceuticals Inc14.98-438.58%
PBYIPuma Biotechnology Inc15.05-440.16%
EXELExelixis Inc15.79-456.99%
NAGENiagen Bioscience Inc16.35-469.65%
CPRXCatalyst Pharmaceuticals Inc17.34-492.02%
MDXGMimedx Group Inc17.38-492.71%
ARGXArgen X SE23.07-621.45%
HALOHalozyme Therapeutics Inc23.20-624.37%
XOMAOXOMA Corp25.34-672.83%
VRTXVertex Pharmaceuticals Inc25.66-679.86%
XOMAPXOMA Corp25.67-680.19%
CTMXCytomX Therapeutics Inc25.70-680.81%
ASNDAscendis Pharma A/S26.35-695.65%
RPRXRoyalty Pharma plc - Class A27.50-721.44%
SLNOSoleno Therapeutics Inc29.02-755.79%
LGNDLigand Pharmaceuticals Inc - Class B30.19-782.26%
BMRNBiomarin Pharmaceutical Inc37.51-947.73%
APLSApellis Pharmaceuticals Inc39.02-981.94%
KRYSKrystal Biotech Inc39.70-997.23%
GMABGenmab40.20-1008.67%
ONCBeiGene Ltd67.03-1614.92%
TECHBio-Techne Corp68.59-1650.36%
VCELVericel Corp80.63-1922.35%
PHARPharming Group N.V.87.74-2083.07%
ALNYAlnylam Pharmaceuticals Inc124.93-2923.71%
TLXTelix Pharmaceuticals Ltd139.89-3261.76%
CORTCorcept Therapeutics Inc158.39-3679.86%